BDBM50265183 (2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-((7-nitrobenzo[c][1,2,5]oxadiazol-4-ylamino)methyl)benzyl)phenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol::CHEMBL500899
SMILES: OCC1OC(C(O)C(O)C1O)c1ccc(Cl)c(Cc2ccc(CNc3ccc([N+]([O-])=O)c4[n-][o+]nc34)cc2)c1
InChI Key: InChIKey=PIWCPYZNGJEWKA-UHFFFAOYSA-N
Data: 1 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sodium/glucose cotransporter 2 (Homo sapiens (Human)) | BDBM50265183 ((2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-((7-nitrobenzo[c...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | 2.40E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Global Research and Development Curated by ChEMBL | Assay Description Inhibition of human SGLT2 expressed in CHO cells assessed as [14C]-alpha-methyl-D-glucopyranoside uptake by fluorescence polarization assay | Bioorg Med Chem Lett 18: 4944-7 (2008) Article DOI: 10.1016/j.bmcl.2008.08.036 BindingDB Entry DOI: 10.7270/Q27944J7 | |||||||||||
More data for this Ligand-Target Pair |